PBM Transparency Moves From Reform Proposal to Pricing Design

Optum Rx’s fee-based PBM model adds market context to DOL’s proposed PBM fee-disclosure rule and the broader push for compensation transparency.

Share
Abstract PBM transparency visual showing fee disclosure pathways, governance traceability, and regulatory oversight signals.
💡
TL;DR:
Optum Rx says it is offering a fee-based PBM model with monthly per-member fees not tied to manufacturer list prices or prescription volume. The announcement does not prove lower costs or regulatory sufficiency, but it adds a market-side signal to DOL’s proposed PBM fee-disclosure rule for ERISA-covered self-insured group health plans.

What you need to know

  • The change: Optum Rx says it is offering a fee-based pharmacy care model that replaces approaches tied to manufacturer-set drug prices or prescription volume with monthly, clearly defined per-member fees. (PharmiWeb.com)
  • Who is affected: Optum Rx PBM customers are the immediate audience for the announced offering. Fiduciaries of ERISA-covered self-insured group health plans and benefits leaders should also watch the issue because DOL’s proposed PBM fee-disclosure rule is aimed at improving transparency into PBM compensation. (Federal Register)
  • Why it matters: The DOL proposal focuses on what compensation information fiduciaries should receive. Optum’s announcement focuses on how one PBM says it will structure and disclose certain fees.
  • What to do first: If responsible for PBM oversight, compare current PBM contract language and reporting against categories appearing across the policy and market conversation: per-member fees, manufacturer payments, GPO-associated fees, spread pricing, and audit rights.
  • Key date or trigger: DOL released the proposed rule on January 29, 2026, and it was published in the Federal Register on January 30, 2026. Optum Rx announced its fee-based model on May 11, 2026. (DOL)

The signal is public. The implications are not.

Members receive deeper analysis and early warnings inside the PolicyEdge AI Intelligence Terminal.

Upgrade to Founding Member
Free risk assessment →